Midterm Results of Intravascular Lithotripsy for Severely Calcified Common Femoral Artery Occlusive Disease: A Single-Center Experience

Abstract

Purpose:

Common femoral artery (CFA)-occlusive disease has traditionally been treated with open surgery, yet nowadays the frailty of patients has induced to find new techniques of revascularisation by endovascular means. So far, intravascular lithotripsy (IVL) has shown promising results in several lower limbs arterial districts. The purpose of this article is to report our experience with IVL for severely calcified peripheral arterial disease (PAD) of the CFA.

Methods:

From November 2018 and October 2020, 10 consecutive patients (12 limbs) treated with IVL were prospectively enrolled in a dedicated database. Inclusion criteria were CFA localization of PAD, with a severe degree of calcification, a lesion length ≥10 mm, and a degree of stenosis ≥70% (severe). The only admitted adjunctive treatment was drug-coated balloon (DCB) angioplasty. Primary outcomes were technical and procedural success, clinical success, and target lesion revascularisation (TLR). Secondary outcomes were target extremity revascularisation (TER) and major adverse events (MAEs).

Results:

All patients underwent IVL with associated DCB angioplasty. The median percentage of achieved stenosis reduction was 55.5% (interquartile range [IQR] 50-60.75), with a technical and procedural success of 100%. Over the study period, TLR only occurred in one limb (8.3%), with a mean upgrade in Rutherford class of 2.7 ± 0.77. No target vessel and access site complications were reported, as well as no distal embolization. One death and one major amputation occurred over the follow-up period, both in the same patient.

Conclusions:

Based on our experience, IVL for selected cases of severely calcified CFA disease, associated with DCB angioplasty, may be considered a safe and effective technique. Of course, a long-term follow-up and a larger series of patients are needed to validate our results.

Keywords

peripheral arterial disease common femoral artery calcified occlusive disease endovascular treatment intravascular lithotripsy

Get full access to this article

View all access options for this article.

References

Siracuse

Gill

Schneider

, et al. Assessing the perioperative safety of common femoral endarterectomy in the endovascular era. Vasc Endovascular Surg. 2014;48(1):27–33. doi:10.1177/1538574413508827.

Park

Won

Kim

, et al. The arterial folding point during flexion of the hip joint. Cardiovasc Intervent Radiol. 2005;28(2):173–177.

Kang

Patel

Conrad

, et al. Common femoral artery occlusive disease: contemporary results following surgical endarterectomy. J Vasc Surg. 2008;48(4):872–877. doi:10.1016/j.jvs.2008.05.025.

Piazza

Ricotta

2nd Bower

, et al. Iliac artery stenting combined with open femoral endarterectomy is as effective as open surgical reconstruction for severe iliac and common femoral occlusive disease. J Vasc Surg. 2011;54(2):402–411. doi:10.1016/j.jvs.2011.01.027.

Wong

Lahsaei

Aoun

, et al. Management of common femoral artery occlusive disease: a review of endovascular treatment strategies and outcomes. Catheter Cardiovasc Interv off J Soc Card Angiogr Interv. 2019;93(3):514–521. doi:10.1002/ccd.27983.

Brodmann

Schwindt

Argyriou

, et al. Safety and feasibility of intravascular lithotripsy for treatment of common femoral artery stenoses. J Endovasc Ther. 2019;26(3):283–287. doi:10.1177/1526602819844998.

Gouëffic

Della Schiava

Thaveau

, et al. Stenting or surgery for De Novo common femoral artery stenosis. JACC Cardiovasc Interv. 2017;10(13):1344–1354. doi:10.1016/j.jcin.2017.03.046.

Brodmann

Werner

Holden

, et al. Primary outcomes and mechanism of action of intravascular lithotripsy in calcified, femoropopliteal lesions: results of Disrupt PAD II. Catheter Cardiovasc Interv off J Soc Card Angiogr Interv. 2019;93(2):335–342. doi:10.1002/ccd.27943.

Adams

Shammas

Mangalmurti

, et al. Intravascular lithotripsy for treatment of calcified lower extremity arterial stenosis: initial analysis of the disrupt PAD III study. J Endovasc Ther. 2020;27(3):473–480. doi:10.1177/1526602820914598.

10.

Patel

Conte

Cutlip

, et al. Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC). J Am Coll Cardiol. 2015;65(9):931–941. doi:10.1016/j.jacc.2014.12.036.

11.

Rutherford

Baker

Ernst

, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg. 1997;26(3):517–538.

12.

Diehm

Pattynama

Jaff

, et al. Clinical endpoints in peripheral endovascular revascularization trials: a case for standardized definitions. Eur J Vasc Endovasc Surg. 2008;36(4):409–419. doi:10.1016/j.ejvs.2008.06.020.

13.

Ranke

Hendrickx

Roth

, et al. Color and conventional image-directed Doppler ultrasonography: accuracy and sources of error in quantitative blood flow measurements. J Clin Ultrasound. 1992;20(3):187–193.

14.

Summary of recommendation statements. Kidney Int Suppl. 2013;3(1):5–14. doi:10.1038/kisup.2012.77.

15.

Kuma

Tanaka

Ohmine

, et al. Clinical outcome of surgical endarterectomy for common femoral artery occlusive disease. Circ J. 2016;80(4):964–969. doi:10.1253/circj.CJ-15-1177.

16.

Andrews

Venbrux

Magee

, et al. Placement of a flexible endovascular stent across the femoral joint: an in vivo study in the swine model. J Vasc Interv Radiol. 1999;10(9):1219–1228.

17.

Nguyen

Amdur

Abugideiri

, et al. Postoperative complications after common femoral endarterectomy. J Vasc Surg. 2015;61(6):1489–1494. doi:10.1016/j.jvs.2015.01.024.

18.

Bonvini

Rastan

Sixt

, et al. Endovascular treatment of common femoral artery disease: medium-term outcomes of 360 consecutive procedures. J Am Coll Cardiol. 2011;58(8):792–798. doi:10.1016/j.jacc.2011.01.070.

19.

Azéma

Davaine

Guyomarch

, et al. Endovascular repair of common femoral artery and concomitant arterial lesions. Eur J Vasc Endovasc Surg. 2011;41(6):787–793. doi:10.1016/j.ejvs.2011.02.025.

20.

Nasr

Kaladji

Vent

, et al. Long-term outcomes of common femoral artery stenting. Ann Vasc Surg. 2017;40:10–18. doi:10.1016/j.avsg.2016.07.088.

21.

Lee

Heikali

Mustapha

, et al. Acute procedural outcomes of orbital atherectomy for the treatment of common femoral artery disease: sub-analysis of the CONFIRM Registries. Vasc Med. 2017;22(4):301–306. doi:10.1177/1358863X17708254.

22.

Das

Mustapha

Indes

, et al. Technique optimization of orbital atherectomy in calcified peripheral lesions of the lower extremities: the CONFIRM series, a prospective multicenter registry. Catheter Cardiovasc Interv: off J Soc Card Angiogr Interv. 2014;83(1):115–122. doi:10.1002/ccd.25046.

23.

Brodmann

Werner

Brinton

, et al. Safety and performance of lithoplasty for treatment of calcified peripheral artery lesions. J Am Coll Cardiol. 2017;70(7):908–910. doi:10.1016/j.jacc.2017.06.022.